SPATA2 and neoplasm: We therefore surmised that SPATA2 and CYLD suppress the production of T-cell chemokines from tumor cells, in part by regulating STAT1 protein levels and restraining STAT1 signaling (but not NF-κB signaling) emanating from IFN-γ stimulation.